Hantz Financial Services Inc. Acquires Shares of 11,346 Bath & Body Works, Inc. (NYSE:BBWI)

Hantz Financial Services Inc. acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 11,346 shares of the company’s stock, valued at approximately $440,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. UMB Bank n.a. boosted its holdings in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after buying an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works during the third quarter worth $39,000. Finally, Friedenthal Financial purchased a new position in Bath & Body Works in the fourth quarter worth $57,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

BBWI stock opened at $37.60 on Friday. The company has a 50 day moving average price of $37.55 and a two-hundred day moving average price of $33.65. The stock has a market capitalization of $8.14 billion, a P/E ratio of 9.17, a PEG ratio of 1.01 and a beta of 1.82. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the firm posted $0.48 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Research analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.13%. Bath & Body Works’s payout ratio is 19.51%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on BBWI shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. TD Cowen upped their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Finally, JPMorgan Chase & Co. lifted their price objective on Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $43.19.

Read Our Latest Research Report on Bath & Body Works

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.